SEC Form 4 · accession 0001144204-15-041417

VACCINOGEN INC · VGEN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director · 10% Owner

Period of report

Feb 9, 2015

Accepted (ET)

Jul 7, 2015 · 5:24 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001453001

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Feb 9, 2015	S	3,000	$3.50	D	282,487	D
Common Stock^F2	Feb 10, 2015	S	71	$3.50	D	282,416	D
Common Stock^F2	Feb 11, 2015	S	1,929	$3.50	D	280,487	D
Common Stock^F3,F2	Feb 19, 2015	S	3,400	$3.58	D	277,087	D
Common Stock^F4,F2	Feb 26, 2015	S	12,744	$3.62	D	264,343	D
Common Stock^F2	Feb 27, 2015	S	2,856	$3.70	D	261,487	D
Common Stock^F2	Mar 3, 2015	S	400	$3.70	D	261,087	D
Common Stock^F2	Mar 20, 2015	S	4,000	$3.75	D	257,087	D
Common Stock^F2	Mar 23, 2015	S	5,000	$3.65	D	252,087	D
Common Stock^F2	Mar 27, 2015	S	3,000	$3.71	D	249,087	D
Common Stock^F2	Mar 30, 2015	S	72	$3.75	D	249,015	D
Common Stock^F5,F2	Mar 31, 2015	S	13,928	$3.70	D	235,087	D
Common Stock^F2	Apr 9, 2015	S	400	$4.00	D	234,687	D
Common Stock^F2	Apr 10, 2015	S	1,000	$4.00	D	233,687	D
Common Stock^F2	Apr 13, 2015	S	2,600	$4.00	D	231,087	D
Common Stock^F2	Apr 14, 2015	S	100	$4.00	D	230,987	D
Common Stock^F2	Apr 17, 2015	S	100	$4.00	D	230,887	D
Common Stock^F2	Apr 21, 2015	S	4,900	$4.00	D	225,987	D
Common Stock^F2	Apr 23, 2015	S	400	$4.00	D	225,587	D
Common Stock^F2	Apr 30, 2015	S	1,000	$3.61	D	224,587	D
Common Stock^F6	holding	—	—		—	3,423,839	I	By Hanna Enterprises, LLC

No Table II lines on this filing.

F1The number of shares reported in Column 5 throughout this filing reflects the number of shares beneficially owned as of the date of this filing and takes into account transactions reported on Form 4 since the date of the transactions reported herein.
F2These shares are owned directly by Michael G. Hanna, Jr.
F3The price reported in Column 4 is the weighted average price. These shares were sold in two transactions at prices of $3.55 and $3.60.
F4The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $3.58 to $3.70, inclusive. The reporting person undertakes to provide to Vaccinogen, Inc., any security holder of Vaccinogen, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5) to this Form 4.
F5The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $3.55 to $3.80, inclusive.
F6These shares are owned directly by Hanna Enterprises, LLC, and indirectly by Michael G. Hanna, Jr. as a member and manager of Hanna Enterprises, LLC.